NORML

DECEMBER 6, 2019

Polish investigators conducted a randomized, double-blind placebo-controlled trial assessing the efficacy of twice-daily transdermal CBD administration on 60 patients with TMD over a period of 14 days. Subjects receiving treatment reported no adverse effects. Subjects receiving treatment reported no adverse effects.

Clinical Trials 110

Clinical Trials Patients CBD Therapy 110

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board. Research in the area of mental health has been Dr. Nitin Desai’s passion. ” About Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. So far, science is telling us that yes cannabis has anti-seizure actions. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98

Therapy CBD Research and Development Treatment 98

Veriheal

JUNE 29, 2021

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. Cannabinoid Therapies for Cancer Patients. Today there are 41 states that have enacted some form of a Right to Try or RTT laws. A Push by Patients.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

SEPTEMBER 2, 2022

The clinical trial involving the use of Filament’s psilocybin received approval from Health Canada and was conducted as part of ATMA Journey Centre’s psychedelic-assisted therapist training program. was the first Canadian private company to engage in legally authorized psilocybin-assisted therapy. ATMA Journey Centers Inc.

Clinical Trials 52

Clinical Trials Therapy Programs Medicine 52

SpeedWeed

MAY 15, 2021

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. The subjects were randomly divided into two groups, each of which received three individual sessions of talk therapy. Image via. View original article.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. FIN also recommended that cannabis and CBD be used in conjunction to “psychological therapies for PTSD.”.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

Clinical Trials 142

Clinical Trials Decriminalization Microdosing Food 142

Veriheal

JULY 18, 2023

This could foster a pool of experts well-versed in applying psychedelic-assisted therapy. Clinical Trials and Reporting The bill breaks new ground by allowing clinical trials to take place regardless of whether the tested substances fall under federal or military statutes.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Cannabis Law Report

AUGUST 7, 2021

We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

NOVEMBER 17, 2022

The Finnish Medicines Agency (Fimea) has granted Clairvoyant Therapeutics, a Canadian drug company, permission to study the effects of psychedelic drug therapies for the treatment of alcohol addiction. Fimea’s approval marks the first time psychedelic drug trials will be carried out in Finland.

Therapy 52

Therapy Clinical Trials Treatment Medicine 52

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

The Joint Blog

NOVEMBER 8, 2020

The study concludes by stating that “To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on [the] quality of life of people with fibromyalgia. mg/mL of THC and 0.51 There were no intolerable adverse effects.

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

Cannabis Law Report

SEPTEMBER 10, 2021

Nick Milne PhD, Co-founder and CSO of Octarine said: “Our core ambition at Octarine is to advance psychedelic therapy across Europe and the world in a way that is consistent with sustainability principles while ensuring patient accessibility.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. Pain and therapy vol. Pain and therapy, 10.1007/s40122-022-00465-y. On the drug front, anti-depressants, analgesics, and muscle relaxants might be prescribed.

THC 144

THC CBD Clinical Trials Sleep 144

Veriheal

JUNE 29, 2022

COMPASS used their own psilocybin, called COMP360, to lead the largest randomized, controlled, double-blind study into psilocybin therapy, the results of which were shared at the American Psychiatric Association’s (APA) annual meeting in New Orleans. Food and Drug Administration (FDA) for the treatment of TRD.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

The Joint Blog

APRIL 16, 2020

According to a new study cannabis may be a useful adjunct therapy for those undergoing radiation therapy, although more research is needed to confirm this. The study is published in the Journal of Medical Imaging and Radiation Sciences and titled Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials.

Therapy 63

Therapy Clinical Trials Patients Cannabinoids 63

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials. Subsection 56(1) Exemption. Conclusion.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

JULY 13, 2022

Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

MMJ Recs

JULY 30, 2024

While conventional therapies such as psychotherapy and medications are widely used, they do not uniformly alleviate symptoms for all individuals. Conventional treatments for PTSD primarily include psychotherapy, such as cognitive behavioral therapy, and medications like antidepressants and anti-anxiety drugs.

Therapy 116

Therapy Treatment Clinical Trials Sleep 116

Cannabis Law Report

MARCH 18, 2022

Husch Blackwell has launched its Psychedelics and Emerging Therapie s team, an interdisciplinary, cross-office group of lawyers capable of addressing the challenges faced by innovators that seek to research, develop and commercialize novel therapies based on psychedelic drugs. By Steve Levine & Marshall Custer. March 18, 2022.

Therapy 52

Therapy Research and Development Clinical Trials Environment 52

Cannabis Law Report

JULY 15, 2021

Halucenex to progress phase II clinical trial to test the efficacy of psilocybin when used to treat Post Traumatic Stress Disorder (PTSD). ? Halucenex’s operation progress continues – USP 61 test protocols complete providing additional validation of psilocybin compounds ahead of Clinical Trial Application. ? 02395733.

Clinical Trials 74

Clinical Trials Therapy Treatment Access 74

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. AK resident? HI resident? CO resident?

Legislation 190

Legislation Decriminalization Access Therapy 190

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. MAPS Public Benefit Corporation will coordinate trial design with Medicines and Healthcare products Regulatory Agency to create a road map for early patient access in the UK. Corine de Boer, M.D.,

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

MAY 6, 2021

EMDMA-001 has been modelled on a major Phase III clinical trial developed by the Multidisciplinary Association for Psychedelic Studies (MAPS).… … Read More.

Clinical Trials 59

Clinical Trials Therapy Programs Medicine 59

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 23, 2021

The company has plans to open three UK psychedelic-assisted psychotherapy clinics where it will deliver ketamine-assisted therapies near term and MDMA when they secure authorization in 2021 (Bristol, London, and Manchester). The company’s target is 20 clinics by the end of 2024. by Toronto-based Awakn Life Sciences Inc.

Clinical Trials 85

Clinical Trials Therapy Research and Development Treatment 85

Veriheal

AUGUST 28, 2023

New therapy exploration suggest potential in using psilocybin for OCD symptoms. And it further reinforces the need to carry out clinical trials to determine the safety and efficiency of using psilocybin to treat OCD. Preliminary findings have suggested that mental health patients could go through psilocybin-assisted therapy.

Treatment 78

Treatment Clinical Trials Therapy Research and Development 78